SCHEMBL8224231

SCHEMBL8224231

O=[N+]([O-])c1c(O)cc(Br)c(O)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.44
▸ GPR35 Q9HC97 3/20 0.43
▸ GRIN2D O15399 5/20 0.40
▸ GRIN3B O60391 5/20 0.40
▸ GRIN1 Q05586 5/20 0.40
▸ GRIN2A Q12879 5/20 0.40
▸ GRIN2B Q13224 5/20 0.40
▸ GRIN2C Q14957 5/20 0.40
▸ GRIN3A Q8TCU5 5/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ CDK2 P24941 1/20 0.38
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ COMT P21964 1/20 0.37
▸ CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9283096 0.79 GPR35 (0.63) TSHRGPR35ALDH1A1CYP1A2CA12
SCHEMBL23229249 0.76 PTGER4 (0.48) TSHRGPR35ALDH1A1CYP1A2CYP2D6
SCHEMBL11098117 0.76 ALDH1A1 (0.50) TSHRGPR35GRIN2DGRIN3BGRIN1
SCHEMBL11589863 0.75 TSHR (0.59) TSHRGPR35GRIN2DGRIN3BGRIN1
SCHEMBL28383634 0.74 TSHR (0.48) TSHRGPR35GRIN2DGRIN3BGRIN1
Ammonia Solution, Strong SCHEMBL20190529 0.74 GPR35 (0.46) TSHRGPR35ALDH1A1CA12CA1
SCHEMBL17251285 0.73 GPR35 (0.41) GPR35ALDH1A1CYP1A2CA12CA1
SCHEMBL17744276 0.71 ALDH1A1 (0.41) TSHRGPR35GRIN2DGRIN3BGRIN1
SCHEMBL17744500 0.71 GRIN2D (0.45) TSHRGPR35GRIN2DGRIN3BGRIN1
SCHEMBL11642626 0.71 CA1 (0.43) TSHRGPR35ALDH1A1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496235-A1 BROMODOMAIN INHIBITORS FOR TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES GlaxoSmithKline LLC (US) 2012-09-12 — — EP disclosed
WO-2011054843-A1 BROMODOMAIN INHIBITORS FOR TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES GLAXOSMITHKLINE LLC (US) 2011-05-12 — — WO disclosed
Send feedback